Try our Advanced Search for more refined results

CardiAQ Valve Technologies, Inc. v. Neovasc Inc. et al

  1. January 18, 2017

    $21M Interest Added To CardiAQ Trade Secrets Win

    A Massachusetts federal judge on Wednesday tacked on more than $21 million in interest to CardiAQ's enhanced trade secrets verdict against Neovasc over a transcatheter mitral valve, bringing the total award to over $111 million.

  2. December 12, 2016

    Facing $91M IP Judgment, Neovasc To Sell Facility

    A federal judge Monday cleared the way for Canadian medical device maker Neovasc to sell part of the company to Boston Scientific to help pay down a $91 million trade secrets and intellectual property verdict.

  3. October 31, 2016

    Judge Adds $21M To CardiAQ's $70M Trade Secrets Win

    A Massachusetts federal judge on Monday tacked $21 million in enhanced damages onto a $70 million trade secrets jury verdict awarded to CardiAQ Valve Technologies Inc. against Neovasc Inc., saying that the extra money was "particularly appropriate" in this case because the misappropriation can't be undone.

  4. September 08, 2016

    Neovasc Fights Injunction Request In $70M IP Verdict

    Medical device maker Neovasc urged a federal court Thursday to deny an injunction request by a rival that won $70 million from it in a trade-secrets trial, arguing there is no justification for the measure.

  5. September 02, 2016

    CardiAQ Says $23M Is Minimum Fair Boost To $70M IP Verdict

    After winning a $70 million trade secrets verdict against medical device maker Neovasc, rival CardiAQ told a federal court on Thursday that the verdict should be enhanced by at least $23.3 million.

  6. August 15, 2016

    New Trial Unlikely After $70M Neovasc Verdict, Judge Says

    A federal judge in Boston said Monday she was reluctant to order a new trial after a $70 million trade secrets verdict against Neovasc, and also unlikely to grant rival medical device maker CardiAQ an injunction preventing a potentially lifesaving product from going to market.

  7. July 28, 2016

    Judge Won't Change $70M Jury Verdict Against Neovasc

    A $70 million verdict against Canadian biotech firm Neovasc, which was accused of stealing patents and trade secrets from a rival device maker, will remain in place after a Massachusetts federal judge on Thursday concluded that neither side was entitled to judgment as a matter of law.

  8. May 27, 2016

    Neovasc Ducks Mass. Law Claim In Medical Device IP Suit

    A Canadian biotech firm recently hit with a $70 million verdict in a patent and trade secrets lawsuit won a reprieve on one of the suit's two pending claims Friday, when a federal judge ruled it wasn't liable for unfair business practices under Massachusetts law because most of the harm occurred in Canada.

  9. May 19, 2016

    Neovasc Hit With $70M Verdict In IP, Trade Secrets Trial

    A Massachusetts federal jury on Thursday slammed Neovasc Inc. with $70 million in damages in a medical device patent lawsuit, finding the Canadian biotech firm stole trade secrets from rival CardiAQ Valve Technologies Inc. when the companies did business together six years ago.

  10. August 20, 2015

    Knobbe Martens Dodges DQ Bid In Neovasc Patent Dispute

    A Massachusetts federal judge on Thursday refused to disqualify Knobbe Martens Olson & Bear LLP from representing a medical device company in a patent suit brought by Canada's Neovasc Inc., which claimed a Knobbe Martens' attorney had represented its subsidiaries in matters involving the same patents.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!